Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Phenyl-salicylate | hsa00030 | Pentose phosphate pathway | 1.69E-02 | 2 | P60891, P37837 | PRPS1, TALDO1 | More | | Phenyl-salicylate | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Phenyl-salicylate | hsa00190 | Oxidative phosphorylation | 1.29E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Phenyl-salicylate | hsa00280 | Valine, leucine and isoleucine degradation | 1.67E-02 | 4 | P55809, Q9HCC0, Q02252, P11310 | OXCT1, MCCC2, ALDH6A1, ACADM | More | | Phenyl-salicylate | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Phenyl-salicylate | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Phenyl-salicylate | hsa00561 | Glycerolipid metabolism | 2.21E-02 | 3 | O14494, P06280, P23743 | PLPP1, GLA, DGKA | More | | Phenyl-salicylate | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Phenyl-salicylate | hsa00600 | Sphingolipid metabolism | 3.96E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Phenyl-salicylate | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.57E-03 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Phenyl-salicylate | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Phenyl-salicylate | hsa00920 | Sulfur metabolism | 8.89E-03 | 1 | Q16762 | TST | More | | Phenyl-salicylate | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Phenyl-salicylate | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Phenyl-salicylate | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Phenyl-salicylate | hsa00983 | Drug metabolism - other enzymes | 1.92E-03 | 5 | P04183, P32320, P05164, Q16772, P09211 | TK1, CDA, MPO, GSTA3, GSTP1 | More | | Phenyl-salicylate | hsa01100 | Metabolic pathways | 8.43E-03 | 11 | P35790, Q16772, P09211, Q9UJ14, P30041, P40926, Q7KZN9, P15121, Q9UHK6, Q86VZ5, Q9BQB6 | CHKA, GSTA3, GSTP1, GGTL3, PRDX6, MDH2, COX15, AKR1B1, AMACR, SGMS1, VKORC1 | More | | Phenyl-salicylate | hsa01230 | Biosynthesis of amino acids | 3.59E-02 | 3 | P60891, Q99707, P37837 | PRPS1, MTR, TALDO1 | More | | Phenyl-salicylate | hsa01524 | Platinum drug resistance | 4.44E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Phenyl-salicylate | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Phenyl-salicylate | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Phenyl-salicylate | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Phenyl-salicylate | hsa03013 | RNA transport | 3.21E-06 | 18 | P62826, O14980, P52298, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, O75822, P78345, P20042, Q14240, P23588, Q9Y6A5, Q14232 | RAN, XPO1, NCBP2, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3J, RPP38, EIF2S2, EIF4A2, EIF4B, TACC3, EIF2B1 | More | | Phenyl-salicylate | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Phenyl-salicylate | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Phenyl-salicylate | hsa03040 | Spliceosome | 8.69E-10 | 17 | Q14562, O43143, O60508, P17844, P08579, P26368, P51991, P61978, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, DDX5, SNRPB2, U2AF2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.803 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.869 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.827 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.866 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.835 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.908 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.928 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.786 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | 0.78 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Phenyl-salicylate | hsa03060 | Protein export | 3.20E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Phenyl-salicylate | hsa04012 | ErbB signaling pathway | 1.34E-02 | 4 | P16333, P19174, P42338, P01106 | NCK1, PLCG1, PIK3CB, MYC | More | | Phenyl-salicylate | hsa04014 | Ras signaling pathway | 4.75E-05 | 11 | P42338, P20827, Q9NRA1, P49767, Q13009, Q7LDG7, P0DP23, P62873, P63218, P50151, P19174 | PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, RASGRP2, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Phenyl-salicylate | hsa04015 | Rap1 signaling pathway | 3.23E-04 | 10 | P20827, Q9NRA1, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P0DP23, P19174 | EFNA1, PDGFC, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, CALM1, PLCG1 | More | | Phenyl-salicylate | hsa04020 | Calcium signaling pathway | 2.61E-02 | 6 | P27987, P21796, P19174, P0DP23, Q9NRA1, P49767 | ITPKB, VDAC1, PLCG1, CALM1, PDGFC, VEGFC | More | | Phenyl-salicylate | hsa04062 | Chemokine signaling pathway | 1.79E-05 | 14 | P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q7LDG7, Q13009, P14598, P42224, P25963, Q8WYR1 | FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, NCF1, STAT1, NFKBIA, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.852 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P43250 | GRK6 | G protein-coupled receptor kinase 6 | -0.775 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.755 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Phenyl-salicylate | hsa04064 | NF-kappa B signaling pathway | 2.30E-04 | 8 | P10415, O00463, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341 | BCL2, TRAF5, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1 | More | | Phenyl-salicylate | hsa04070 | Phosphatidylinositol signaling system | 1.12E-02 | 5 | P19174, P0DP23, P42338, P23743, P27987 | PLCG1, CALM1, PIK3CB, DGKA, ITPKB | More | | Phenyl-salicylate | hsa04071 | Sphingolipid signaling pathway | 5.96E-05 | 7 | P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Phenyl-salicylate | hsa04072 | Phospholipase D signaling pathway | 4.67E-02 | 5 | P42338, P19174, Q14344, P23743, Q9NRA1 | PIK3CB, PLCG1, GNA13, DGKA, PDGFC | More | | Phenyl-salicylate | hsa04080 | Neuroactive ligand-receptor interaction | 1.05E-03 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21730, Q16581, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1, ADRB2 | More | | Phenyl-salicylate | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | | Phenyl-salicylate | hsa04122 | Sulfur relay system | 8.89E-03 | 1 | Q16762 | TST | More | | Phenyl-salicylate | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Phenyl-salicylate | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | | Phenyl-salicylate | hsa04141 | Protein processing in endoplasmic reticulum | 3.42E-04 | 7 | P18848, Q15437, O60337, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, MARH6, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Phenyl-salicylate | hsa04145 | Phagosome | 4.79E-03 | 10 | P60709, Q15075, Q15080, P14598, Q13509, Q13488, P05164, O60603, P35443, P13765 | ACTB, EEA1, NCF4, NCF1, TUBB3, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Phenyl-salicylate | hsa04146 | Peroxisome | 2.42E-02 | 5 | O43933, P56589, Q9UKG9, O75521, P33121 | PEX1, PEX3, CROT, ECI2, ACSL1 | More | | Phenyl-salicylate | hsa04151 | PI3K-Akt signaling pathway | 2.96E-05 | 23 | P62753, P42338, P43657, P01106, P27348, P20827, Q9NRA1, P49767, P07900, P08238, Q8WYR1, P62873, P63218, P50151, O15335, Q13751, P22105, P14784, P01568, Q99941, P18848, O00141, P30281 | RPS6, PIK3CB, P2RY5, MYC, YWHAQ, EFNA1, PDGFC, VEGFC, HSP90AA1, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, CHAD, LAMB3, TNXB, IL2RB, IFNA21, CREBL1, ATF4, SGK, CCND3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P20827 | EFNA1 | Ephrin-A1 | -0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q9NRA1 | PDGFC | Platelet-derived growth factor C | -0.702 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O15335 | CHAD | Chondroadherin | -0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 |
| Phenyl-salicylate | hsa04210 | Apoptosis | 3.83E-03 | 8 | Q13315, P10415, O76075, P24522, Q16548, P43234, P18848, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | | Phenyl-salicylate | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Phenyl-salicylate | hsa04217 | Necroptosis | 5.63E-05 | 10 | P23458, Q9NQC7, P07900, P15104, P05141, P01584, P0C0S5, Q13557, Q9H444, O75351 | JAK1, CYLD, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B, VPS4B | More | | Phenyl-salicylate | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Phenyl-salicylate | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Phenyl-salicylate | hsa04360 | Axon guidance | 3.83E-03 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Phenyl-salicylate | hsa04371 | Apelin signaling pathway | 9.23E-05 | 10 | P62873, P63218, P50151, Q8WYR1, Q13370, Q14814, Q14344, Q13485, P84022, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Phenyl-salicylate | hsa04380 | Osteoclast differentiation | 4.17E-02 | 4 | Q9NQC7, Q9UQC2, P23458, P01584 | CYLD, GAB2, JAK1, IL1B | More | | Phenyl-salicylate | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Phenyl-salicylate | hsa04612 | Antigen processing and presentation | 3.90E-03 | 6 | P13765, P48382, P26715, P26717, Q13241, P01732 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A | More | | Phenyl-salicylate | hsa04613 | Neutrophil extracellular trap formation | 2.06E-05 | 24 | P42338, P19174, P11215, O60603, P05164, P08246, Q9UM07, Q13547, P04908, Q6FI13, Q93077, P62807, Q93079, P68431, P21796, P14598, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PIK3CB, PLCG1, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, H2AC4; H2AC8, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC9, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, VDAC1, NCF1, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Phenyl-salicylate | hsa04614 | Renin-angiotensin system | 3.52E-02 | 1 | P10619 | CTSA | More | | Phenyl-salicylate | hsa04620 | Toll-like receptor signaling pathway | 4.00E-02 | 4 | P01568, P42224, P25963, P42338 | IFNA21, STAT1, NFKBIA, PIK3CB | More | | Phenyl-salicylate | hsa04623 | Cytosolic DNA-sensing pathway | 3.67E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Phenyl-salicylate | hsa04625 | C-type lectin receptor signaling pathway | 2.17E-02 | 5 | Q9ULY5, P42224, P25963, P42338, P0DP23 | CLEC4E, STAT1, NFKBIA, PIK3CB, CALM1 | More | | Phenyl-salicylate | hsa04650 | Natural killer cell mediated cytotoxicity | 2.96E-02 | 6 | O60880, P20963, Q13241, P26718, P26717, P26715 | SH2D1A, CD247, KLRD1, KLRK1, KLRC2, KLRC1 | More | | Phenyl-salicylate | hsa04657 | IL-17 signaling pathway | 3.87E-03 | 8 | P07900, O00463, Q16539, P14780, Q9UJX4, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, MMP9, ANAPC5, LCN2, TNF, IL1B | More | | Phenyl-salicylate | hsa04658 | Th1 and Th2 cell differentiation | 3.11E-05 | 13 | P25963, Q04759, P07766, P20963, P09693, P19174, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | NFKBIA, PRKCQ, CD3E, CD247, CD3G, PLCG1, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Phenyl-salicylate | hsa04659 | Th17 cell differentiation | 8.02E-05 | 15 | P25963, Q04759, P19174, P42224, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, PLCG1, STAT1, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | | Phenyl-salicylate | hsa04660 | T cell receptor signaling pathway | 1.00E-02 | 7 | Q9UDY8, Q04759, P10747, Q08881, P20963, P09693, P01732 | MALT1, PRKCQ, CD28, ITK, CD247, CD3G, CD8A | More | | Phenyl-salicylate | hsa04662 | B cell receptor signaling pathway | 5.25E-04 | 6 | P25963, P42338, P60033, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Phenyl-salicylate | hsa04664 | Fc epsilon RI signaling pathway | 8.73E-04 | 4 | P42338, P07948, P19174, P09917 | PIK3CB, LYN, PLCG1, ALOX5 | More | | Phenyl-salicylate | hsa04666 | Fc gamma R-mediated phagocytosis | 2.92E-02 | 4 | P07948, P42338, P19174, P14598 | LYN, PIK3CB, PLCG1, NCF1 | More | | Phenyl-salicylate | hsa04713 | Circadian entrainment | 4.00E-02 | 4 | P0DP23, P62873, P63218, P50151 | CALM1, GNB1, GNG5, GNG10 | More | | Phenyl-salicylate | hsa04714 | Thermogenesis | 6.01E-04 | 8 | Q16539, P51828, P62753, P33121, P12074, O15239, Q16718, O14521 | MAPK14, ADCY7, RPS6, ACSL1, COX6A1, NDUFA1, NDUFA5, SDHD | More | | Phenyl-salicylate | hsa04724 | Glutamatergic synapse | 2.92E-02 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Phenyl-salicylate | hsa04725 | Cholinergic synapse | 3.93E-04 | 10 | P51828, P22694, Q14643, P62873, P63218, P50151, P18848, Q13557, P42338, P10415 | ADCY7, PRKACB, ITPR1, GNB1, GNG5, GNG10, ATF4, CAMK2D, PIK3CB, BCL2 | More | | Phenyl-salicylate | hsa04727 | GABAergic synapse | 8.14E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | | Phenyl-salicylate | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Phenyl-salicylate | hsa04744 | Phototransduction | 1.32E-02 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Phenyl-salicylate | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.00E-02 | 4 | P19174, P42338, P24723, P0DP23 | PLCG1, PIK3CB, PRKCH, CALM1 | More | | Phenyl-salicylate | hsa04810 | Regulation of actin cytoskeleton | 2.61E-02 | 6 | P12814, Q13009, P42338, P11215, Q14344, Q9NRA1 | ACTN1, TIAM1, PIK3CB, ITGAM, GNA13, PDGFC | More | | Phenyl-salicylate | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Phenyl-salicylate | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Phenyl-salicylate | hsa04914 | Progesterone-mediated oocyte maturation | 4.00E-02 | 4 | P42338, Q13370, P30304, P08238 | PIK3CB, PDE3B, CDC25A, HSP90AB1 | More | | Phenyl-salicylate | hsa04915 | Estrogen signaling pathway | 9.55E-04 | 9 | P14780, P22694, Q99941, P18848, P51828, P07900, P11142, Q14643, P10415 | MMP9, PRKACB, CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, ITPR1, BCL2 | More | | Phenyl-salicylate | hsa04918 | Thyroid hormone synthesis | 6.10E-04 | 6 | P22694, P51828, Q99941, P18848, Q14643, P02768 | PRKACB, ADCY7, CREBL1, ATF4, ITPR1, ALB | More | | Phenyl-salicylate | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Phenyl-salicylate | hsa04924 | Renin secretion | 1.75E-03 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Phenyl-salicylate | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Phenyl-salicylate | hsa04926 | Relaxin signaling pathway | 8.42E-04 | 9 | P25963, P42338, P62873, P63218, P50151, Q99941, P18848, P49767, P51828 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7 | More | | Phenyl-salicylate | hsa04927 | Cortisol synthesis and secretion | 2.37E-04 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | | Phenyl-salicylate | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.14E-04 | 7 | Q14643, P51828, P22694, P23771, Q99941, P18848, P10415 | ITPR1, ADCY7, PRKACB, GATA3, CREBL1, ATF4, BCL2 | More | | Phenyl-salicylate | hsa04932 | Non-alcoholic fatty liver disease | 7.78E-05 | 11 | P49841, O43521, P18848, O75460, P01584, P13073, P12074, O15239, Q16718, O95298, O14521 | GSK3B, BCL2L11, ATF4, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFA5, NDUFC2, SDHD | More | | Phenyl-salicylate | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Phenyl-salicylate | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Phenyl-salicylate | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Phenyl-salicylate | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Phenyl-salicylate | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Phenyl-salicylate | hsa04971 | Gastric acid secretion | 4.51E-02 | 3 | Q08828, P15311, P0DP23 | ADCY1, VIL2, CALM1 | More | | Phenyl-salicylate | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Phenyl-salicylate | hsa05012 | Parkinson disease | 7.03E-03 | 11 | O15239, P13073, P05141, P21796, P60604, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509 | NDUFA1, COX4I1, SLC25A5, VDAC1, UBE2G2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3 | More | | Phenyl-salicylate | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Phenyl-salicylate | hsa05020 | Prion disease | 3.73E-04 | 11 | P13591, P01584, P11142, O15239, Q16718, O14521, P13073, P18848, P05141, P49841, Q16539 | NCAM1, IL1B, HSPA8, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, SLC25A5, GSK3B, MAPK14 | More | | Phenyl-salicylate | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.47E-03 | 12 | P49841, O15239, Q16718, O14521, P13073, P18848, Q13561, P05141, Q16539, P01584, Q08752, Q13557 | GSK3B, NDUFA1, NDUFA5, SDHD, COX4I1, ATF4, DCTN2, SLC25A5, MAPK14, IL1B, PPID, CAMK2D | More | | Phenyl-salicylate | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Phenyl-salicylate | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Phenyl-salicylate | hsa05032 | Morphine addiction | 7.60E-03 | 5 | P62873, P63218, P50151, Q13370, P43250 | GNB1, GNG5, GNG10, PDE3B, GRK6 | More | | Phenyl-salicylate | hsa05034 | Alcoholism | 6.32E-03 | 7 | Q13547, P0DP23, P62873, P63218, P50151, P62807, Q93079 | HDAC1, CALM1, GNB1, GNG5, GNG10, HIST1H2BC, H2BC9 | More | | Phenyl-salicylate | hsa05110 | Vibrio cholerae infection | 4.50E-03 | 4 | Q13488, P17252, P19174, P60709 | TCIRG1, PRKCA, PLCG1, ACTB | More | | Phenyl-salicylate | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.89E-03 | 2 | Q99437, P41240 | ATP6V0B, CSK | More | | Phenyl-salicylate | hsa05132 | Salmonella infection | 2.36E-02 | 8 | P25963, P08238, P01106, P42338, O75369, Q71U36, Q13509, P49754 | NFKBIA, HSP90AB1, MYC, PIK3CB, FLNB, TUBA1A, TUBB3, VPS41 | More | | Phenyl-salicylate | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Phenyl-salicylate | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Phenyl-salicylate | hsa05140 | Leishmaniasis | 4.75E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | Phenyl-salicylate | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Phenyl-salicylate | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Phenyl-salicylate | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Phenyl-salicylate | hsa05162 | Measles | 1.56E-03 | 9 | P01568, P25963, P42224, P14784, P07766, P42338, P11142, P01584, Q9NP90 | IFNA21, NFKBIA, STAT1, IL2RB, CD3E, PIK3CB, HSPA8, IL1B, RAB9B | More | | Phenyl-salicylate | hsa05163 | Human cytomegalovirus infection | 4.19E-04 | 10 | P42338, P25963, P62873, P63218, P50151, P0DP23, Q14344, P01106, P30101, P01568 | PIK3CB, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, MYC, PDIA3, IFNA21 | More | | Phenyl-salicylate | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 7.49E-05 | 11 | P01568, P42224, P25963, P42338, P62873, P63218, P50151, P19174, P07948, P01106, P0DP23 | IFNA21, STAT1, NFKBIA, PIK3CB, GNB1, GNG5, GNG10, PLCG1, LYN, MYC, CALM1 | More | | Phenyl-salicylate | hsa05168 | Herpes simplex virus 1 infection | 4.57E-02 | 10 | P25963, P01568, P42224, Q07955, Q01130, Q13243, P30101, P42338, Q13398, O75820 | NFKBIA, IFNA21, STAT1, SFRS1, SFRS2, SFRS5, PDIA3, PIK3CB, ZNF211, ZNF189 | More | | Phenyl-salicylate | hsa05169 | Epstein-Barr virus infection | 1.08E-03 | 11 | P01106, Q13547, P25963, P42338, P07948, P30101, Q13761, O75293, P42224, P01568, P07766 | MYC, HDAC1, NFKBIA, PIK3CB, LYN, PDIA3, RUNX3, GADD45B, STAT1, IFNA21, CD3E | More | | Phenyl-salicylate | hsa05170 | Human immunodeficiency virus 1 infection | 3.24E-03 | 10 | P42338, P62873, P63218, P50151, P0DP23, P30101, P01568, P25963, P19174, P07766 | PIK3CB, GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, NFKBIA, PLCG1, CD3E | More | | Phenyl-salicylate | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Phenyl-salicylate | hsa05200 | Pathways in cancer | 7.17E-05 | 23 | Q13751, P42338, P08238, P42224, P25963, P19174, P01106, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P62873, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P01568, P14784 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, MYC, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNB1, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IFNA21, IL2RB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.805 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.926 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.838 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.711 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.932 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01106 | MYC | Myc proto-oncogene protein | 0.719 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.887 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q13547 | HDAC1 | Histone deacetylase 1 | 0.701 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P49767 | VEGFC | Vascular endothelial growth factor C | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.764 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.846 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.799 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.847 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P0DP23 | CALM1 | Calmodulin-1 | 0.826 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P01568 | IFNA21 | Interferon alpha-21 | -0.701 | P40925 | MDH1 | Malate dehydrogenase, cytoplasmic | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.912 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 |
| Phenyl-salicylate | hsa05202 | Transcriptional misregulation in cancer | 9.05E-05 | 17 | Q12778, Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13077, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, TRAF1, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Phenyl-salicylate | hsa05203 | Viral carcinogenesis | 1.11E-05 | 16 | Q12933, Q99941, P18848, P42229, P42338, P06746, P07948, P27348, P29083, Q13547, Q15283, P12814, P25963, P61978, P62807, Q93079 | TRAF2, CREBL1, ATF4, STAT5A, PIK3CB, POLB, LYN, YWHAQ, GTF2E1, HDAC1, RASA2, ACTN1, NFKBIA, HNRPK, HIST1H2BC, H2BC9 | More | | Phenyl-salicylate | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Phenyl-salicylate | hsa05206 | MicroRNAs in cancer | 2.79E-02 | 7 | P30304, P09493, P01106, P42338, Q13547, P20827, P19174 | CDC25A, TPM1, MYC, PIK3CB, HDAC1, EFNA1, PLCG1 | More | | Phenyl-salicylate | hsa05212 | Pancreatic cancer | 3.94E-02 | 4 | P42338, P84022, Q13485, O75293 | PIK3CB, SMAD3, SMAD4, GADD45B | More | | Phenyl-salicylate | hsa05214 | Glioma | 1.34E-02 | 4 | P0DP23, P42338, P19174, O75293 | CALM1, PIK3CB, PLCG1, GADD45B | More | | Phenyl-salicylate | hsa05218 | Melanoma | 2.31E-02 | 3 | Q9NRA1, P42338, O75293 | PDGFC, PIK3CB, GADD45B | More | | Phenyl-salicylate | hsa05220 | Chronic myeloid leukemia | 1.15E-03 | 7 | Q13547, P01106, Q13485, P25963, P84022, P42338, O75293 | HDAC1, MYC, SMAD4, NFKBIA, SMAD3, PIK3CB, GADD45B | More | | Phenyl-salicylate | hsa05223 | Non-small cell lung cancer | 3.99E-02 | 4 | P17252, O43524, P19174, O75293 | PRKCA, FOXO3, PLCG1, GADD45B | More | | Phenyl-salicylate | hsa05231 | Choline metabolism in cancer | 3.73E-04 | 7 | P42338, Q9NRA1, Q9Y259, P19174, P23743, O14494, P17252 | PIK3CB, PDGFC, CHKB, PLCG1, DGKA, PLPP1, PRKCA | More | | Phenyl-salicylate | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.82E-03 | 10 | P25963, P42338, P19174, P07766, P20963, P09693, P42224, O60603, P10747, Q04759 | NFKBIA, PIK3CB, PLCG1, CD3E, CD247, CD3G, STAT1, TLR2, CD28, PRKCQ | More | | Phenyl-salicylate | hsa05321 | Inflammatory bowel disease | 8.69E-05 | 6 | O60603, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Phenyl-salicylate | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Phenyl-salicylate | hsa05332 | Graft-versus-host disease | 6.43E-05 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | | Phenyl-salicylate | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Phenyl-salicylate | hsa05415 | Diabetic cardiomyopathy | 3.22E-04 | 12 | P17252, P05141, P14598, Q15080, O15239, Q16718, O14521, P13073, Q16539, P49841, Q13557, P04406 | PRKCA, SLC25A5, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, COX4I1, MAPK14, GSK3B, CAMK2D, GAPDH | More | | |